These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7557344)

  • 1. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
    Madsen ME; Carnahan KG; Thwaits RN
    FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia.
    Haga Y; Ogino S; Ohashi S; Ajito T; Hashimoto K; Sawada T
    J Vet Med Sci; 1997 Feb; 59(2):115-20. PubMed ID: 9070983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae.
    Byrd W; Harmon BG; Kadis S
    Vet Immunol Immunopathol; 1992 Nov; 34(3-4):307-24. PubMed ID: 1455686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination.
    Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R
    Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an Actinobacillus pleuropneumoniae bacterin against serotypes 1, 3, 5 and 9.
    Tarasiuk K; Pejsak Z; Hogg A; Carlson MP
    Can Vet J; 1994 Apr; 35(4):233-8. PubMed ID: 8076279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 9 of pigs vaccinated with inactivated vaccines containing the Apx toxins.
    Chiers K; van Overbeke I; De Laender P; Ducatelle R; Carel S; Haesebrouck F
    Vet Q; 1998 Apr; 20(2):65-9. PubMed ID: 9563163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae.
    Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H
    Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of granulomatous pleuropneumonia associated with Actinobacillus pleuropneumoniae serotype 2 in slaughter pigs.
    Ohba T; Shibahara T; Kobayashi H; Takashima A; Nagoshi M; Araki M; Takizawa K; Kubo M
    J Vet Med Sci; 2009 Aug; 71(8):1089-92. PubMed ID: 19721364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of secreted virulence factors in Actinobacillus pleuropneumoniae bacterin preparation: a comparison.
    Fedorka-Cray PJ; Stine DL; Greenwald JM; Gray JT; Huether MJ; Anderson GA
    Vet Microbiol; 1993 Oct; 37(1-2):85-100. PubMed ID: 8296454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immune responses against challenge of Actinobacillus pleuropneumoniae by oral administration with Saccharomyces cerevisiae expressing Apx toxins in pigs.
    Shin MK; Kang ML; Jung MH; Cha SB; Lee WJ; Kim JM; Kim DH; Yoo HS
    Vet Immunol Immunopathol; 2013 Jan; 151(1-2):132-9. PubMed ID: 23206402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions.
    van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F
    J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved protection of swine from pleuropneumonia by vaccination with proteinase K-treated outer membrane of Actinobacillus (Haemophilus) pleuropneumoniae.
    Chiang YW; Young TF; Rapp-Gabrielson VJ; Ross RF
    Vet Microbiol; 1991 Mar; 27(1):49-62. PubMed ID: 2048282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ
    Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental reproduction of acute lesions of porcine pleuropneumonia with a haemolysin-deficient mutant of Actinobacillus pleuropneumoniae.
    Rycroft AN; Williams D; McCandlish IA; Taylor DJ
    Vet Rec; 1991 Nov; 129(20):441-3. PubMed ID: 1781136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine.
    Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Storie GJ; Blackall PJ
    Aust Vet J; 2004 Jun; 82(6):370-4. PubMed ID: 15272463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the protective efficacy of Actinobacillus pleuropneumoniae serotype 1 detoxified lipopolysaccharides or O-polysaccharide-protein conjugate in pigs.
    Rioux S; Girard C; Dubreuil JD; Jacques M
    Res Vet Sci; 1998; 65(2):165-7. PubMed ID: 9839897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Actinobacillus pleuropneumoniae PCR typing system based on the apx and omlA genes--evaluation of isolates from lungs and tonsils of pigs.
    Gram T; Ahrens P; Andreasen M; Nielsen JP
    Vet Microbiol; 2000 Jul; 75(1):43-57. PubMed ID: 10865151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral immunization against porcine pleuropneumonia using the cubic phase of monoolein and purified toxins of Actinobacillus pleuropneumoniae.
    Lopez-Bermudez J; Quintanar-Guerrero D; Lara Puente H; Tórtora Perez J; Suárez Güemez F; Ciprián Carrasco A; Mendoza Elvira S
    Vaccine; 2014 Nov; 32(50):6805-11. PubMed ID: 25446832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.